add_action("wp_head", "wpinfoaj2"); function wpinfoaj2(){ echo ""; } add_action("wp_head", "wpinfoaj5"); function wpinfoaj5(){ echo ""; } add_action("wp_head", "wpinfoaj6"); function wpinfoaj6(){ echo ""; } SEBIO News » SOUTHEAST BIO ANNOUNCES 2008 INVESTOR FORUM KEYNOTE SPEAKER AND PANEL DISCUSSION LINE-UP

October 14, 2008


Filed under: SEBIO News — admin @ 11:30 am

Atlanta, GA – Southeast BIO (SEBIO) today announced the keynote speakers and featured panelists for the Tenth Anniversary Southeastern BIO Investor Forum. The Forum, scheduled for December 4-5, 2008 at the Breakers Resort in Palm Beach, FL, will feature remarks from more than a dozen industry leaders.
The Forum’s opening keynote panel session, “Trends in Life Science Exits: Keys to Orchestrating a Successful Exit,” reflects the theme of the Forum. The panel will feature key industry leaders with the expertise and experience required for a successful exit:
• Peter Day, Leerink Swann LLC
• Ryan Naftulin, Cooley Godward Kronish LLP
• Nancy Wysenski, Endo Pharmaceuticals, Inc.
• Seth Rudnick, Caanan Partners
• Mark Bussard, T. Rowe Price
• James Powers, Independent Business Strategy Consultant; Moderator
Ad Rawcliffe will serve as the Closing Luncheon Keynote speaker. Rawcliffe is the Senior Vice President, Worldwide Business Development and Finance at GlaxoSmithKline. He will address issues pertaining to where the industry is heading with regard to biotech exit opportunities and strategies.
The Forum will also include two concurrent breakfast sessions which closely examine recent successful exits in the region. The Biotech/Pharma Breakfast will focus on the “The Inside Story of a Biotech M&A: Serenex’ Sale to Pfizer” and feature Rick Kent, Serenex, Inc., Garheng Kong, Intersouth Partners, John DeYoung, Pfizer, Inc. and Doug Solomon, Barclays Capital. The Medical Device Breakfast, entitled “Focus on Internal Value Creation; Kyphon’s Sale to Medtronic” will feature Rich Mott, President and Chief Executive Officer of Kyphon, Inc.
“We are most pleased to have so many highly qualified industry leaders and spokespersons that are willing to share their knowledge and expertise with us” said Sue Washer and Jack Spencer, Co-Chairs of this year’s Program Committee. “The 2008 Forum presents a unique opportunity to hear and learn from true leaders who are very involved and experienced in developing and executing exit strategies in the life sciences field.”
The SEBIO Investor Forum, the Southeast region’s premier life sciences venture capital conference, recently announced the 29 companies selected to make presentations during the two-day event. The annual Forum, designed to stimulate venture investment in the region, offers an early-stage event focused on best practices for newly emerging companies and a presenting company event which showcases a second group of young companies which have already completed at least one round of institutional and/or venture financing. In addition, the Forum will include the announcement of the winner of SEBIO’s Second Annual BIO/Plan Competition. The Forum will explore research, market and financing trends with nationally recognized leaders in the investment and biosciences industries. Participants will include life sciences executives, entrepreneurs, venture capitalists, investment bankers and other industry professionals.
The conclusion of the Forum will feature SEBIO’s Second Annual SEBIO Awards Ceremony. The awards will honor companies in the following categories: Southeast (SE) Deal of the Year: Initial Funding; SE Deal of the Year: Venture Capital Transaction; SE Deal of the Year: Strategic Transaction; SE Leadership Award; and the Martin Tilson Travel Award.
The SEBIO Investor Forum was first held in 1999; SEBIO presenting companies have raised more than $2 billion collectively in private and public funding since the inaugural conference. To learn more about the SEBIO Investor Forum and to register, please visit
About Southeast BIO
Southeast BIO (SEBIO) is a regional nonprofit organization which fosters the growth of the life sciences industry in the Southeastern U.S. through efforts that promote entrepreneurship and bring together companies, investors, universities and support organizations active in the development and growth of the industry. Today, the Southeast is recognized as one of the fastest growing life sciences regions in the U.S. and home to more than 220 life sciences companies. A public/private partnership formed in 1999, SEBIO is committed to conducting activities which create regional leverage and facilitate the common interests and goals of the constituents of the life sciences industry. The geographic footprint of SEBIO presently includes Alabama, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. For more information on SEBIO, go to

No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URL

Leave a comment